Evaluation of Inteiueukin-1 Receptor Antagonist (Il-1ra) and Tumor Necrosis Factor Binding Protein (TNF-BP) in a Rodent Abscess Model of Host Resistance

References

• Lebrec H., Blot C., Pequet S., Roger R., Bohoun C., Pallardy M. Immunotoxicologial Investigation Using Pharmaceutical Drugs: In Vivo Evaluation of Immune Function. FAT 1994; 23: 159
   PubMedGoogle Scholar
• House R. V., Thomas P. T., Bhargava H. N. Selective Modulation of Immune Function Resulting from In Vitro Exposure to Methylenedioxymethamphetamine (ectasy). Toxicology 1995; 96: 59
   PubMed Web of Science ®Google Scholar
• Weissinger J. Nonclinical Pharmacologic and Toxicologic Considerations for Evaluating Biologic Products. Regulatory Toxicology and pharmacology 1989; 10: 255
   Google Scholar
• Dinarello C. A. Biology of Interleukin-1. FASEB J. 1988; 2: 108
   PubMed Web of Science ®Google Scholar
• Sharar S. R., Winn R. K., Murry C. E., Harlan J. M., Rice C. L. A CD 18 Monoclonal Antibody Increases the Incidence and Severity of Subcutaneous Abscess Formation after High-Dose Staphylococcus aureus Injection in Rabbits. Surgery 1991; 110: 213
   PubMed Web of Science ®Google Scholar
• Duff G. W. Clinical Applications of Cytokines, J. Oppenheim, Rossio, Gearing. Oxford University Press, New York 1993; 263, ch. 15
   Google Scholar
• Dinarello C. A. Role of Interleukin-1 in Infectious Diseases. Immunol. Rev 1992; 127: 119
   PubMedGoogle Scholar
• Elliott M J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H., Woody J. N. Randomised Double-Blind Comparison of Chimeric Monoclonal Antibody to Tumor Necrois Factor-γ (cA2) Versus Placebo in Rheumatoid Arthritis. The Lancet 1994; 344: 1105
   PubMed Web of Science ®Google Scholar
• Russell D. A., Tucker K. K., Chinookoswong N., Thompson R. C., Kohno T. Combined Inhibition of Interleukin-1 and Tumor Necrosis Factor in Rodent Endotoxemia: Improved Survival and Organ Function. J. Inf. Dis 1995; 171: 1528
   PubMed Web of Science ®Google Scholar
• Espat N. J., Cendan J. C., Beierle E. A., Auffenberg T. A., Rosenberg J., Russell D., Kenney J. S., Fischr E., Montegut W., Lowry S. F., Copeland E. M., Moldawer L. L. PEG-BP-30 Monotherapy Attenuates the Cytokine-Mediated Inflammatory Cascade in Baboon Escherichia coli Septic Shock. J. Surg. Res. 1995; 59: 153
   PubMedGoogle Scholar
• Faherty D. A., Claudy V., Plocinski J. M., Kaffka K., Kilian P., Thompson R. C., Benjamin W. R. Failure of IL-1 Receptor antagonist and Monoclonal Anti-IL-1 Receptor Antibody to Inhibit Antigen-Specific Immune Responses In Vivo. JI 1992; 148: 766
   Google Scholar
• Granowitz E. V., Clark B. D., Mancilla J., Dinarello C. A. Interleukin-1 Receptor Antagonist Competitively Inhibits the Binding of Interleukin-1 to the Type II Interleukin-1 Receptor. JBC 1991; 266: 14147
   PubMed Web of Science ®Google Scholar
• Carter D. B., Deibel M. R., Dunn C. J., Tomich C. S., Laborde A. L., Slighton J. L., Berger A. E., Bienkowski M. J., Sun F. F., McEwan R. N., et al. Purification, Cloning, Expression, and Biological Characterization of an Interleukin-1 Receptor Antagonist Protein. Nature 1990; 344: 633
   PubMed Web of Science ®Google Scholar
• DuPasquier L. Fundamental Immunology, W. E. Paul. Raven Press. 1993; 199
   Google Scholar
• Beutler B., Milsark I. W., Cerami A. Passive Immunization against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin. Science 1985; 229: 869
   PubMed Web of Science ®Google Scholar
• Havell E. A., Moldawer L. L., Helfgott D., Kilian P. L., Sehgal P. B. Type I IL-1 Receptor Blockade Exacerbates Murine Listeriosis. J. Immunology 1992; 148: 1486
   PubMedGoogle Scholar
• Nakane A., Minagawa T., Kato L. Endogenous Tumor Necrosis Factor (Cachectin) is Essential to Host Resistance against Listeria Monocytogenes Infection. Infection and Immunology 1988; 56: 2563
   PubMed Web of Science ®Google Scholar
• Hale K. K., Smith C. G., Baker S. L., Vanderslice R. W., Squires C. H., Gleason T. M., Tucker K. K., Kohno T., Russell D. A. Multifunctional Regulation of the Biological Effects of TNF-γ by the Soluble Type I and Type II TNF Receptors. Cytokine 1995; 7: 26
   PubMed Web of Science ®Google Scholar
• Citak M. S., Cue J. I., Peyton J. C., Malangoni M. A. The Critical Relationship of Antibiotic Dose and Bacterial Contamination in Experimental Infection. Journal of Surgical Research 1992; 52: 127
   Google Scholar
• Pun Y. L. W., Barraclough D. R. E., Muirden K. D. Leg Ulcers in Rheumatoid Arthritis. The Medical Journal of Australia 1990; 153: 585
   Google Scholar
• van Furth R., van Zwet T. L., Buisman A. M., van Dissel J. T. Anti-Tumor Necrosis Factor Antibodies Inhibit the Influx of Granulocytes and Monocytes into an Inflammatory Exudate and Enhance the Growth of Listeria monocytogenes in Various Organs. JID 1994; 170: 234
   PubMedGoogle Scholar
• Hannum C. H., Wilcox C. J., Arend W. P. Primary Structure and Functional Expression from Complementary DNA of a Human Interleukin-1 Receptor Antagonist. Nature 1990; 343: 336
   PubMed Web of Science ®Google Scholar
• Bomberger C. E., Haar J. L. Dexamethasone and Hydrocortisone Enhance the in vitro Migration of Prethymic Stem Cells to Thymus Supernatant. Thymus 1992; 20: 89
   Google Scholar
• Renzi P. M., Livenstein R., Martin J. G. Effect of Dexamethasone on Airway Inflammation and Responsiveness After Antigen Challenge of the Rat. Am. Rev. Respir. Dis. 1993; 148: 932, (Surendra)
   Google Scholar
• Rinehart J., Delamater E. W., Keville L., Measel J. Corticosteroid Modulation of IL-1 Hematopoietic Effects and Toxicity in a Murine System. Blood 1994; 84: 1457
   PubMed Web of Science ®Google Scholar
• Luscinskas F. W., Cybulsky M. I., Kiely J-M., Peckins C. S., David V. M., Gimbrone M. A. Cytokine-activated Human Endothelial Monolayers Support Enhanced Neutrophil Transmigration via a Mechanism Involving Both Endothelial-leukocyte Adhesion Molecule-1 and Intercellular Adhesion Molecule-1. JI 1991; 146: 1617
   Google Scholar
• Tracey K. J. TNF and Mae West or: Death from too Much of a Good Thing. The Lancet 1995; 345: 75
   Google Scholar
• Eisenberg S. P., Thompson R. C., Cox G. N. an interleukin-1 inhibitor (IL-1i) blocks IL-1 induced adhesion of neutrophils to endothelial cells. Second International workshop on cytokines. 1992, (abstract # 106)
   Google Scholar
• Sharer S. R., Sasaki S. S., Flaherty L. C., Paulson J. C., Harlan J. M., Winn R. K. P-Selectin Blockade does not Impair Leukocyte Host Defense against Bacterial Peritonitis and Soft Tissue Infection in Rabbits. J. Immunology 1993; 9: 4982
   Google Scholar